Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury. | Int J Mol Sci | 2023 | 37298645 | PubTator, text mining | PubMed |
| The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37292151 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro. | Biochem Soc Trans | 2023 | 37264940 | PubTator, text mining | PubMed |
| Reverse Cholesterol Transport of Macrophages Repurposed for Hepatitis B Virus Entry. | Cell Mol Gastroenterol Hepatol | 2023 | 37244293 | PubTator, text mining | PubMed |
| Bile Salts by the Back Road. | Cell Mol Gastroenterol Hepatol | 2023 | 37244292 | PubTator, text mining | PubMed |
| Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein. | Viruses | 2023 | 37243280 | PubTator, text mining | PubMed |
| Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections. | Viruses | 2023 | 37243197 | PubTator, text mining | PubMed |
| The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation. | Viruses | 2023 | 37243124 | PubTator, text mining | PubMed |
| Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. | Nutrients | 2023 | 37242293 | PubTator, text mining | PubMed |
| Role of Extracellular Vesicles in Liver Diseases. | Life (Basel) | 2023 | 37240762 | PubTator, text mining | PubMed |
| Epidemiology Pattern, Prevalent Genotype Distribution, Fighting Stigma and Control Options for Hepatitis D in Bulgaria and Other European Countries. | Life (Basel) | 2023 | 37240760 | PubTator, text mining | PubMed |
| Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities. | Int J Mol Sci | 2023 | 37240057 | PubTator, text mining | PubMed |
| Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes. | Int J Mol Sci | 2023 | 37239939 | PubTator, text mining | PubMed |
| Screening of Membrane Protein Production by Comparison of Transient Expression in Insect and Mammalian Cells. | Biomolecules | 2023 | 37238687 | PubTator, text mining | PubMed |
| LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation. | Anal Cell Pathol (Amst) | 2023 | 37234237 | PubTator, text mining | PubMed |
| Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37229456 | PubTator, text mining | PubMed |
| Zavegepant: First Approval. | Drugs | 2023 | 37227596 | PubTator, text mining | PubMed |
| Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies. | PLoS Pathog | 2023 | 37224147 | PubTator, text mining | PubMed |
| Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection. | J Inflamm Res | 2023 | 37223107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=21